Filing Flows

Filing Flows › Pediatrix Medical Group (MD) › Q4 2025

Pediatrix Medical Group (MD) Q4 2025 earnings results (fourth quarter 2025)

10-K filed Feb 19, 2026

Pediatrix Medical Group (MD) reported revenue of $494M for the fourth quarter 2025 (Q4 2025), -2% from a year earlier and +0.2% from the quarter before. Operating margin was 9.9%, net earnings $33.7M (6.8% of revenue).

Revenue$494M
Year over year-2%
Quarter over quarter+0.2%
Operating margin9.9%
Net earnings$33.7M

Pediatrix Medical Group, Q4 2025: revenue $494M (-2% year over year), operating margin 9.9%, net earnings $33.7M, operating cash flow $114M. The chart follows the revenue to costs, profit and cash.

Q4 2025AmountQ/QY/Y
Revenue$494M+0.2%-2%
Operating profit$48.8M-28%+24%
Net earnings$33.7M-53%+11%
Operating cash flow$114M-17%-14%
Free cash flow$109M-18%-16%

What changed

Revenue was $493.8M in Q4 2025, down 2% year over year and roughly flat from the previous quarter. Health Care Patient Service was the largest line at 85% of revenue.

Operating profit was $48.8M, a 9.9% margin (up 2.1 points year over year). Total costs fell 4% while revenue fell 2%. Net earnings were $33.7M, up 11% year over year. The effective tax rate was 26.1%.

Operating cash flow was $114.1M (down 14% year over year), 339% of net earnings. Non-cash charges added back $5.6M of depreciation and amortization and $5.3M of share-based compensation. Working capital and other items added $69.4M. Capital expenditures of $5.3M left free cash flow of $108.8M.

Questions

What was Pediatrix Medical Group's revenue in the fourth quarter 2025?

Pediatrix Medical Group (MD) reported revenue of $494M for the fourth quarter 2025 (Q4 2025), -2% from a year earlier and +0.2% from the quarter before.

Was Pediatrix Medical Group profitable in the fourth quarter 2025?

Operating profit was $48.8M (9.9% of revenue) and net earnings $33.7M.

Open the interactive Sankey →

Source: Pediatrix Medical Group 10-K on SEC EDGAR.